Exploratory analysis of a prognosis predictive formula for metastatic colorectal cancer treated with chemotherapy.

被引：0
|
作者：
Tanaka, Mamoru
Kusaba, Hitoshi
Mukaide, Satomi
Kishimoto, Junji
Kumagai, Hozumi
Makiyama, Akitaka
Shirakawa, Tsuyoshi
Oda, Hisanobu
Komoda, Masato
Mitsugi, Kenji
Akashi, Koichi
Baba, Eishi
机构：
[1] Kyushu Univ Hosp, Dept Hematol & Oncol, Fukuoka 812, Japan
[2] Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka 812, Japan
[3] Kyushu Univ Hosp, Dept Res & Dev Next Generat Med, Fac Med Sci, Fukuoka 812, Japan
[4] Japan Community Hlth Care Org Kyushu Hosp, Dept Hematol Oncol, Fukuoka, Japan
[5] Natl Hosp Org Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan
[6] Kyushu Natl Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka, Japan
[7] Natl Hosp Org Kyushu Med Ctr, Dept Med Oncol, Fukuoka, Japan
[8] Hamanomachi Hosp, Dept Med Oncol, Fukuoka, Japan
[9] Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Fukuoka 812, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.757
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
757
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Chemotherapy of metastatic colorectal cancer
    Saad E.D.
    Hoff P.M.
    Current Treatment Options in Gastroenterology, 2005, 8 (3) : 239 - 247
  • [42] Chemotherapy in metastatic colorectal cancer
    Kelly, Claire
    Cassidy, Jim
    SURGICAL ONCOLOGY-OXFORD, 2007, 16 (01): : 65 - 70
  • [43] Chemotherapy of metastatic colorectal cancer
    Modest, D. P.
    Hiddemann, W.
    Heinemann, V.
    INTERNIST, 2014, 55 (01): : 37 - 42
  • [44] Irinotecan and mitomycin C (MMC) as salvage therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidine, irinotecan and/or oxaliplatin based chemotherapy.
    Rodriguez, I
    Viudez, A
    Salgado, E
    García-Foncillas, J
    De La Cámara, J
    Espinós, J
    Garrán, C
    Chopitea, A
    Fernández-Hidalgo, O
    Martín-Algarra, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 308S - 308S
  • [45] Therapy monitoring with FDG-PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.
    Dimitrakopoulou-Strauss, A
    Rudi, J
    Strauss, LG
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 113P - 113P
  • [46] Association of genetic variations in genes implicated in the axis with outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with cetuximab plus chemotherapy.
    Miyamoto, Yuji
    Stintzing, Sebastian
    Heinemann, Volker
    Zhang, Wu
    Cao, Shu
    Okazaki, Satoshi
    Berger, Martin D.
    Suenaga, Mitsukuni
    Schirripa, Marta
    Soni, Shivani
    Matsusaka, Satoshi
    Ning, Yan
    Yang, Dongyun
    Gopez, Roel
    Melendez, Elizabeth
    Hanna, Diana L.
    Barzi, Afsaneh
    Baba, Hideo
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Durable Complete Responses in Metastatic Colorectal Cancer Treated with Chemotherapy Alone
    Ferrarotto, Renata
    Pathak, Priyanka
    Maru, Dipen
    Agarwal, Atin
    Overman, Michael
    Hoff, Paulo M.
    Kopetz, Scott
    CLINICAL COLORECTAL CANCER, 2011, 10 (03) : 178 - 182
  • [48] Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy
    Miscoria, Manuela
    Tonetto, Fabrizio
    Deroma, Laura
    Machin, Piernicola
    Di Loreto, Carla
    Driol, Pamela
    Minisini, Alessandro Marco
    Russo, Stefania
    Andreetta, Claudia
    Mansutti, Mauro
    Damante, Giuseppe
    Fasola, Gianpiero
    Puglisi, Fabio
    ANTI-CANCER DRUGS, 2012, 23 (03) : 326 - 334
  • [49] Assessing QoL in patients with metastatic colorectal cancer (mCRC) treated with chemotherapy
    Miller, KL
    Johnson, LL
    Colwell, HH
    Bhattacharyya, SK
    Deeter, RG
    Mathias, SD
    VALUE IN HEALTH, 2005, 8 (06) : A49 - A49
  • [50] Second-line bevacizumab plus FOLFOX in patients with metastatic colorectal cancer previously treated with adjuvant oxaliplatin-based chemotherapy.
    Chun, Sang Hoon
    Kim, Jung Hoon
    Kwag, Seung-Jin
    Kang, Myoung Hee
    Park, Ji-Ho
    Lee, Gyeong-Won
    Kang, Jung Hun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 157 - 157
12345